Department of Radiotherapy and Experimental Cancer Research, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Paul Scherrer Institut, Villigen, Switzerland.
Sci Rep. 2019 Mar 18;9(1):4755. doi: 10.1038/s41598-019-41283-1.
We report on a dosimetrical study comparing supine (S) and prone-crawl (P) position for radiotherapy of whole breast (WB) and loco-regional lymph node regions, including the internal mammary chain (LN_IM). Six left sided breast cancer patients were CT-simulated in S and P positions and four patients only in P position. Treatment plans were made using non-coplanar volumetric modulated arc photon therapy (VMAT) or pencil beam scanning intensity modulated proton therapy (IMPT). Dose prescription was 15*2.67 Gy(GyRBE). The average mean heart doses for S or P VMAT were 5.6 or 4.3 Gy, respectively (p = 0.16) and 1.02 or 1.08 GyRBE, respectively for IMPT (p = 0.8; p < 0.001 for IMPT versus VMAT). The average mean lung doses for S or P VMAT were 5.91 or 2.90 Gy, respectively (p = 0.002) and 1.56 or 1.09 GyRBE, respectively for IMPT (p = 0.016). In high-risk patients, average (range) thirty-year mortality rates from radiotherapy-related cardiac injury and lung cancer were estimated at 6.8(5.4-9.4)% or 3.8(2.8-5.1)% for S or P VMAT (p < 0.001), respectively, and 1.6(1.1-2.0)% or 1.2(0.8-1.6)% for S or P IMPT (p = 0.25), respectively. Radiation-related mortality risk could outweigh the ~8% disease-specific survival benefit of WB + LN_IM radiotherapy for S VMAT but not P VMAT. IMPT carries the lowest radiation-related mortality risks.
我们报告了一项比较仰卧位(S)和俯卧位爬行(P)体位进行全乳(WB)和局部区域淋巴结区域(包括内乳链(LN_IM))放射治疗的剂量学研究。6 名左侧乳腺癌患者在 S 和 P 位置进行 CT 模拟,4 名患者仅在 P 位置进行模拟。使用非共面容积调制弧形光子治疗(VMAT)或笔形束扫描强度调制质子治疗(IMPT)制定治疗计划。处方剂量为 15*2.67 Gy(GyRBE)。S 或 P VMAT 的平均心脏剂量分别为 5.6 或 4.3 Gy(p = 0.16),IMPT 的平均心脏剂量分别为 1.02 或 1.08 GyRBE(p = 0.8;p < 0.001 与 VMAT 相比)。S 或 P VMAT 的平均肺剂量分别为 5.91 或 2.90 Gy(p = 0.002),IMPT 的平均肺剂量分别为 1.56 或 1.09 GyRBE(p = 0.016)。在高危患者中,估计 S 或 P VMAT 放疗相关心脏损伤和肺癌 30 年死亡率分别为 6.8(5.4-9.4)%或 3.8(2.8-5.1)%(p < 0.001),S 或 P IMPT 分别为 1.6(1.1-2.0)%或 1.2(0.8-1.6)%(p = 0.25)。S VMAT 的放疗相关死亡率风险可能超过 WB + LN_IM 放疗的 8%左右疾病特异性生存获益,但 P VMAT 则不然。IMPT 带来的放疗相关死亡率风险最低。